[Trial of chemotherapy with a new antimitotic derivative].
D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D002277:Carcinoma / Q000188:drug therapy*; D003630:Daunorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005354:Fibrosarcoma / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000009:adverse effects; D007680:Kidney Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D009362:Neoplasm Metastasis / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D006835:Hydrazones; D003630:Daunorubicin
Essai de chimiothérapie avec un nouveau dérivé antimitotique.